Jonathan B. Perlin, Pres-Clinical Operations & CMO at HCA Healthcare, Inc. (HCA), sold 275,455 shares at $199.91 ($50.3M) on 2021-04-27, disclosed to the SEC on 2021-04-27.
Open-market sale of $50.3M HCA by Pres-Clinical Operations & CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $200.03 | 37,305 | $7.5M | 14.8% |
| 2 | $200.03 | 37,305 | $7.5M | 14.8% |
| 3 | $202.50 | 74,065 | $15.0M | 29.8% |
| 4 | $0.00 | 25,000 | $0 | 0.0% |
| 5 | $199.91 | 38,390 | $7.7M | 15.3% |
| 6 | $199.91 | 38,390 |
| $7.7M |
| 15.3% |
| 7 | $200.08 | 25,000 | $5.0M | 9.9% |
| Total | $182.51 avg | 275,455 | $50.3M | 100% |
| Filing → |
| HCA | SELL | 2020-11-09 | $1.6M | — | Filing → |
| HCA | SELL | 2018-07-27 | $18.8M | — | Filing → |
| HCA | SELL | 2018-06-25 | $1.4M | — | Filing → |